From surviving to thriving — precision care for every patient, every stage.
Oncology is witnessing a paradigm shift with the integration of artificial intelligence and genomics, transforming the way cancers are detected, diagnosed, and treated. AI-powered tools are redefining tumour imaging, enabling greater accuracy in detection and risk stratification, while predictive models are offering clinicians deeper insight into disease progression and therapy response. Genomic-guided cancer care is moving from the laboratory bench to the bedside, creating real patient pathways where treatment decisions are tailored to individual molecular profiles.
Yet the evolution of oncology in the era of AI and genomics also raises important questions of accessibility, affordability, and long-term sustainability. This year’s Oncology track will critically examine the reality of AI in oncology — distinguishing genuine breakthroughs from hype — while showcasing patient-centred examples of genomic-guided care, from newer paradigms in precision oncology to holistic, whole-person cancer care that integrates pain management, palliative support, and integrative medicine.
What delegates can expect:
Last year at Clinovate:
Delegates experienced an exclusive showcase of Proton Therapy at Apollo Proton Cancer Centre, Chennai — South Asia’s first proton centre — alongside a virtual talk by Dr Saurabh Dahiya of Stanford University on the current landscape and future of cellular therapy, and a spirited debate on AI in oncology that drew one of the day’s largest audiences.